Ajax Therapeutics

Imago BioSciences

This biopharmaceutical company develops small molecule inhibitors to treat patients with myeloproliferative neoplasms and other bone marrow diseases.

Damora Therapeutics

This biotechnology company develops subcutaneous biologics to treat patients with mutant calreticulin-driven myeloproliferative neoplasms and other chronic blood disorders.

Atavistik Bio

This biotechnology company develops oral allosteric small molecule therapeutics for patients with rare hematological diseases and cancers.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

HDAX Therapeutics

This biotechnology company develops small molecule inhibitors targeting the HDAC6 protein to treat patients with neuropathies, heart failure and various cancer conditions.

Myosin Therapeutics

This biopharmaceutical company develops small molecule therapies targeting molecular nanomotors to treat aggressive cancers and neurological disorders for patients with unmet medical needs.

Constellation Pharmaceuticals

This biopharmaceutical company develops small-molecule epigenetics therapies to treat patients with blood cancers and solid tumours.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.